Your browser doesn't support javascript.
loading
Innate Immunity in Type 1 Diabetes.
Bertrand, Léo; Chervonsky, Alexander V; Lehuen, Agnès.
Afiliação
  • Bertrand L; Université Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France.
  • Chervonsky AV; Laboratoire d'Excellence Inflamex, Université Paris Cité, 75014 Paris, France.
  • Lehuen A; Department of Pathology, Committee on Immunology, Committee on Microbiology, The University of Chicago, Chicago, Illinois 60637, USA.
Article em En | MEDLINE | ID: mdl-39074873
ABSTRACT
Type 1 diabetes (T1D) results from the destruction of pancreatic ß cells by the immune system, to which both pancreatic ß-cell dysfunction and pathological activation of the immune system contribute. This paper is focused on understanding the modalities of this activation, and the genetic and environmental factors increasing its risk. Innate immunity has a critical role in the loss of self-tolerance and promotion of inflammation either directly using innate effector mechanisms or by providing activation signals to anti-islet adaptive autoimmunity. We provide an overview of various deleterious and protective roles of innate immunity in T1D inside pancreatic islets, regional lymph nodes, and distant locations such as the gut.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article